Source: Annual Congress 2006 - Assessment of respiratory pathophysiology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Ishii, K. Okazaki, T. Fukuda (Mibu, Japan). Clinical utility of impulse oscillation system (IOS) for the assessment of clinical status and therapeutic efficacy in patients with COPD. Eur Respir J 2006; 28: Suppl. 50, 2469

Member's Comments

No comment yet.

Related content which might interest you: The use of forced oscillation technique (FOT) in assessment and stratification of disease severity in elderly COPD patients Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases Year: 2011 Clinical, functional and laboratory assessment of treatment efficacy in COPD patients Source: International Congress 2014 – Predictors Year: 2014 The relationship between impulse oscillometry (IOS) and health status in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 423s Year: 2003 Development of a tool to measure the clinical response to biologic therapy in uncontrolled severe asthma: the FEOS score. Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 The effects of standard therapy for COPD patients on FEV1 are associated with lower score of the Goddard classification Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Clinical phenotyping of COPD patients: a simple tool with prognosis value Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 The clinical utility of forced oscillation technique during hospitalisation in patients with exacerbation of COPD Source: ERJ Open Res, 7 (4) 00448-2021; 10.1183/23120541.00448-2021 Year: 2021 The clinical usefulness of spirometric information Source: Breathe 2008; 5: 214-220 Year: 2009 Do marker states improve measurement properties of utility instruments: a randomized multi-center trial in patients with chronic respiratory disease Source: Eur Respir J 2004; 24: Suppl. 48, 295s Year: 2004 The effectiveness of different clinical measures in evaluating response to omalizumab Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma Year: 2010 Impulse oscillometry assessment of small airway dysfunction pre- and post-bronchodilator in asthma and its relationship to disease severity Source: International Congress 2014 – Alterations of exercise and lung function in different diseases Year: 2014 COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009 Clinical relevance of constant power exercise duration changes in COPD Source: Eur Respir J 2009; 33: 340-345 Year: 2009 Is impulse oscillometry (IOS) better than spirometry for monitoring treatment outcomes in adult cystic fibrosis (CF) pulmonary exacerbations? A pilot study Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 The usefulness of the impulse oscillometry for predicting the treatment outcomes of bronchial thermoplasty in patients with severe asthma. Source: International Congress 2018 – Asthma analysis Year: 2018 Clinical prognostic tools and their use in COPD. Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Clinical utility of the respiratory center response to hypercapnia in OHS patients Source: International Congress 2018 – New insights in the management of chronic respiratory failure Year: 2018 Emerging concepts in outcome assessment for COPD clinical trials Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease Year: 2007 A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012